Premier Value Childrens Cetirizine

Cetirizine Hydrochloride


Pharmacy Value Alliance Llc
Human Otc Drug
NDC 68016-165
Premier Value Childrens Cetirizine also known as Cetirizine Hydrochloride is a human otc drug labeled by 'Pharmacy Value Alliance Llc'. National Drug Code (NDC) number for Premier Value Childrens Cetirizine is 68016-165. This drug is available in dosage form of Solution. The names of the active, medicinal ingredients in Premier Value Childrens Cetirizine drug includes Cetirizine Hydrochloride - 5 mg/5mL . The currest status of Premier Value Childrens Cetirizine drug is Active.

Drug Information:

Drug NDC: 68016-165
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Premier Value Childrens Cetirizine
Also known as the trade name. It is the name of the product chosen by the labeler.
Proprietary Name Base: Premier Value
The base of the Brand/Proprietary name excluding its suffix.
Proprietary Name Suffix: Childrens Cetirizine
A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Cetirizine Hydrochloride
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Pharmacy Value Alliance Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Solution
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CETIRIZINE HYDROCHLORIDE - 5 mg/5mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: ANDA
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 08 Sep, 2011
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 15 Jan, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: ANDA090182
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Pharmacy Value Alliance LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:1014673
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0840986028632
UPC stands for Universal Product Code.
UNII:64O047KTOA
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:Histamine H1 Receptor Antagonists [MoA]
Histamine-1 Receptor Antagonist [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
68016-165-001 BOTTLE in 1 CARTON (68016-165-00) / 120 mL in 1 BOTTLE08 Sep, 2011N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antihistamine

Product Elements:

Premier value childrens cetirizine cetirizine hydrochloride cetirizine hydrochloride cetirizine acetic acid glycerin methylparaben propylene glycol propylparaben water sodium acetate anhydrous sucralose colorless to slightly yellow sugar free

Indications and Usage:

Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat

Warnings:

Warnings do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine. ask a doctor before use if you have liver or kidney disease. your doctor should determine if you need a different dose. ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives. when using this product drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery stop use and ask a doctor if an allergic reaction to this product occurs. seek medical help right away. if pregnant or breast-feeding: if breast-feeding: not recommended if pregnant: ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away. (1-800-222-1222)

Do Not Use:

Warnings do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine. ask a doctor before use if you have liver or kidney disease. your doctor should determine if you need a different dose. ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives. when using this product drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery stop use and ask a doctor if an allergic reaction to this product occurs. seek medical help right away. if pregnant or breast-feeding: if breast-feeding: not recommended if pregnant: ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away. (1-800-222-1222)

When Using:

When using this product drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery

Dosage and Administration:

Directions use only with enclosed dosing cup find right dose on chart below ml = milliliter adults and children 6 years and over 5 ml or 10 ml once daily depending upon severity of symptoms; do not take more than 10 ml in 24 hours. adults 65 years and over 5 ml once daily; do not take more than 5 ml in 24 hours. children 2 to under 6 years of age 2.5 ml once daily. if needed, dose can be increased to a maximum of 5 ml once daily or 2.5 ml every 12 hours. do not give more than 5 ml in 24 hours. children under 2 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Stop Use:

Stop use and ask a doctor if an allergic reaction to this product occurs. seek medical help right away.

Package Label Principal Display Panel:

Principal display panel - 120 ml bottle carton compare to the active ingredient in children's zyrtec ® * premier value ® 2 yrs. & older children's cetirizine hydrochloride oral solution 1 mg/ml antihistamine allergy sugar free grape flavor indoor & outdoor allergies 24 hour relief of: sneezing runny nose itchy, watery eyes itchy throat or nose dosing cup included 4 fl oz (120 ml) independently tested pv satisfaction guaranteed principal display panel - 120 ml bottle carton

Further Questions:

Questions? call 1-866-923-4914


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.